References
[1] Lean, M.E.J., Leslie, W.S., Barnes, A.C., et al. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541-551.
[2] Lean, M.E.J., Leslie, W.S., Barnes, A.C., et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. (2019). Lancet Diabetes Endocrinol 7(5):344-355.
[3] Lim, E.L., Hollingsworth, K.G., Aribisala, B.S., et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. (2011). Diabetologia 54(10):2506-14.
[4] Taheri, S., Zaghloul, H., Chagoury, O., et al. (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group randomised controlled trial. Lancet 8(6):477-489.
[5] Astbury, N.M., Aveyard, P., Nickless, A., et al. (2018). Doctor referral of overweight people to low energy total diet replacement treatment (DROPLET): pragmatic randomised controlled trial. BMJ 362:K3760.
[6] Christensen, P, Meinert Larsen, T, et al. (2018). Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low‐energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab 20: 2840– 2851.
[7] Morris, E., Aveyard, P., Dyson, P., et al. (2019). A food-based, low-energy, low-carbohydrate diet for people with type 2 diabetes in primary care: A randomized controlled feasibility trial. Diabetes Obes Metab 22(4):512-520.